<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30180968</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>09</Month>            <Day>20</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>20</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1879-0038</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>675</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>30</Day>                    </PubDate>                </JournalIssue>                <Title>Gene</Title>                <ISOAbbreviation>Gene</ISOAbbreviation>            </Journal>            <ArticleTitle>SPC24 Regulates breast cancer progression by PI3K/AKT signaling.</ArticleTitle>            <Pagination>                <MedlinePgn>272-277</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0378-1119(18)30786-8</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gene.2018.07.017</ELocationID>            <Abstract>                <AbstractText>Breast cancer is a heterogeneous disease, presenting as several diverse clinical and histologic varieties and it is now the most frequently diagnosed cancer and is the sixth leading cause of cancer-related death in Chinese women. SPC24 is an important component of the mitotic checkpoint machinery and its carcinogenic roles have been shown in several cancers, including anaplastic thyroid cancer, hepatocellular carcinoma, and osteosarcoma. However, the role of SPC24 in breast cancer is still unclear. Here, we show SPC24 is highly expressed in breast cancer compared with the normal tissues. In addition, we observe that SPC24 knockdown can lead to attenuated cell growth, increased cell apoptosis and cell cycle progression. Consistent with the breast cancer cell results, the in vivo growth of the SPC24-knocking down cells was significantly inhibited. Interestingly, molecular analysis indicates that SPC24 regulates PI3K/AKT kinase pathway, indicating the important of SPC24 for clinical treatment. In aggregate, our results provide an oncogenic functionality of SPC24 in breast cancer progression.</AbstractText>                <CopyrightInformation>Copyright Â© 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Zhou</LastName>                    <ForeName>Juan</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>The Affiliated XuZhou Hospital of Medical College of Southeast University, Xuzhou, People's Republic of China; Department of Medical Oncology, Affiliated to Medical College of Southeast University and Xuzhou Central Hospital, Xuzhou, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pei</LastName>                    <ForeName>Yunfeng</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>The Affiliated XuZhou Hospital of Medical College of Southeast University, Xuzhou, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chen</LastName>                    <ForeName>Geng</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai 200241, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cao</LastName>                    <ForeName>Chunping</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>The Affiliated XuZhou Hospital of Medical College of Southeast University, Xuzhou, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Liu</LastName>                    <ForeName>Jia</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>The Affiliated XuZhou Hospital of Medical College of Southeast University, Xuzhou, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ding</LastName>                    <ForeName>Chen</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>The Affiliated XuZhou Hospital of Medical College of Southeast University, Xuzhou, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Duping</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>The Affiliated XuZhou Hospital of Medical College of Southeast University, Xuzhou, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sun</LastName>                    <ForeName>Li</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>The Affiliated XuZhou Hospital of Medical College of Southeast University, Xuzhou, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Xu</LastName>                    <ForeName>Peng</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University, 415 Fengyang Road, Shanghai 200003, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Niu</LastName>                    <ForeName>Guoping</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>The Affiliated XuZhou Hospital of Medical College of Southeast University, Xuzhou, People's Republic of China; Department of Medical Oncology, Affiliated to Medical College of Southeast University and Xuzhou Central Hospital, Xuzhou, People's Republic of China. Electronic address: gp_niu15@163.com.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>06</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Gene</MedlineTA>            <NlmUniqueID>7706761</NlmUniqueID>            <ISSNLinking>0378-1119</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C484695">SPC24 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.1.-</RegistryNumber>                <NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.11.1</RegistryNumber>                <NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008869" MajorTopicYN="N">Microtubule-Associated Proteins</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D023041" MajorTopicYN="N">Xenograft Model Antitumor Assays</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Cell growth</Keyword>            <Keyword MajorTopicYN="N">PI3K/AKT</Keyword>            <Keyword MajorTopicYN="N">SPC24</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>06</Month>                <Day>12</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>07</Month>                <Day>04</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>05</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30180968</ArticleId>            <ArticleId IdType="pii">S0378-1119(18)30786-8</ArticleId>            <ArticleId IdType="doi">10.1016/j.gene.2018.07.017</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>